Business Description
BioAdaptives Inc
NAICS : 311999
SIC : 5199
ISIN : US09072U2069
Total Employee Number:
1Compare
Compare
Traded in other countries / regions
BDPT.USA IPO Date
2014-07-09Description
BioAdaptives Inc is engaged in investigating, marketing, and distributing natural plant, algal, and cyanobacteria-based products and medical devices that enhance health and wellness for humans and animals, with a focus on nootropics, anti-aging, weight control, relaxation, pain relief, and anti-viral properties. The company's current products in development include dietary supplements utilizing natural ingredients and proprietary methods to optimize the availability of nutrients in foods and beverages. The human products are designed to aid in cognitive health, regenerative stem cell activation, and healthy weight loss. The company's products include MyndMed, Zeranovia, and Wynovia.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | -15.71 | |||||
Debt-to-Equity | -0.21 | |||||
Debt-to-EBITDA | -0.35 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -162.38 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -56.3 | |||||
3-Year EBITDA Growth Rate | 42.4 | |||||
3-Year EPS without NRI Growth Rate | 55.9 | |||||
3-Year FCF Growth Rate | 45.1 | |||||
3-Year Book Growth Rate | 41 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.75 | |||||
9-Day RSI | 37.89 | |||||
14-Day RSI | 37.09 | |||||
6-1 Month Momentum % | -39.23 | |||||
12-1 Month Momentum % | -84.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.05 | |||||
Quick Ratio | 0.04 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 2221.29 | |||||
Days Payable | 803 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -92.5 | |||||
Shareholder Yield % | -19.79 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 70.83 | |||||
Operating Margin % | -4129.17 | |||||
Net Margin % | -6133.33 | |||||
EBITDA Margin % | -5487.5 | |||||
FCF Margin % | -2095.83 | |||||
OCF Margin % | -2095.83 | |||||
ROA % | -846.95 | |||||
ROIC % | -61.17 | |||||
3-Year ROIIC % | -58.77 | |||||
ROC (Joel Greenblatt) % | -8813.33 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4 | |||||
EV-to-EBIT | -0.33 | |||||
EV-to-EBITDA | -0.33 | |||||
EV-to-Revenue | 17.96 | |||||
EV-to-FCF | -0.86 | |||||
Earnings Yield (Greenblatt) % | -303.03 | |||||
FCF Yield % | -1047.92 |
GF Valueâ„¢
BioAdaptives Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioAdaptives Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 2:1 Stock Split | 2025-01-23 | 0.07 (-6.67%) | ||
| 0.00333333:1 Stock Split | 2024-11-21 | 0.02 (-60.00%) |
Show
Entries
Guru Commentaries on OTCPK:BDPT
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| BioAdaptives Announces Nationwide Launch of Lung Fortress(TM) Natural Supplement | 2023-10-10 |
Articles on BioAdaptives Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers